Compare · FTRE vs ILMN
FTRE vs ILMN
Side-by-side comparison of Fortrea Holdings Inc. (FTRE) and Illumina Inc. (ILMN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FTRE and ILMN operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $33.97B, about 19.6x FTRE ($1.74B).
- Over the past year, FTRE is up 103.7% and ILMN is up 127.9% - ILMN leads by 24.3 points.
- ILMN has been more active in the news (11 items in the past 4 weeks vs 9 for FTRE).
- Both have 25 recent analyst ratings on file.
- Company
- Fortrea Holdings Inc.
- Illumina Inc.
- Price
- -
- -
- Market cap
- $1.74B
- $33.97B
- 1M return
- -4.77%
- +18.79%
- 1Y return
- +103.68%
- +127.94%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 9
- 11
- Recent ratings
- 25
- 25
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Latest FTRE
- Chief Operating Officer Morais Mark A. converted options into 11,313 shares and sold $88,985 worth of shares (4,892 units at $18.19), increasing direct ownership by 9% to 77,786 units (SEC Form 4) to cover withholding tax
- New insider Russell Carrie Elizabeth claimed ownership of 1,780 shares (SEC Form 3)
- Chief Executive Officer Thakral Anshul sold $2,026,284 worth of shares (111,857 units at $18.11), decreasing direct ownership by 35% to 204,940 units (SEC Form 4) (for withholding tax)
- Chief Executive Officer Thakral Anshul converted options into 416,666 shares and sold $1,913,111 worth of shares (99,869 units at $19.16) (SEC Form 4) (withholding tax)
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 4 filed by Interim CFO Smith David Ross
- Director Sanders Machelle sold $174,697 worth of shares (9,700 units at $18.01), decreasing direct ownership by 21% to 36,399 units (SEC Form 4)
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 144 filed by Fortrea Holdings Inc.
- SEC Form 10-Q filed by Fortrea Holdings Inc.
Latest ILMN
- Director Meister Keith A. sold $145,556,398 worth of shares (679,574 units at $214.19) (SEC Form 4)
- SVP, Strategy/Corp Development Wedel Christensen Jakob sold $197,840 worth of shares (1,033 units at $191.52), decreasing direct ownership by 7% to 14,023 units (SEC Form 4)
- SEC Form 8-K filed by Illumina Inc.
- Illumina Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 8-K filed by Illumina Inc.
- SEC Form 3 filed by new insider Coletti Julie Ann
- SEC Form FWP filed by Illumina Inc.
- Chief Commercial Officer Sullivan Michael C was granted 4,503 shares (SEC Form 4)
- Illumina Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Director Meister Keith A. sold $148,159,897 worth of shares (741,127 units at $199.91) (SEC Form 4)